Cardiovascular Health

The Pharmacy Times® Cardiovascular Health Resource Center is a comprehensive resource for clinical news and expert insights on the health of the heart and blood vessels, including coronary heart disease, stroke, heart failure, heart arrhythmias, and heart valve issues.

Clinical Overview: Rivaroxaban (Xarelto) for Multiple Cardiovascular Conditions

June 30, 2022

Article

Rivaroxaban is the only FDA-approved anticoagulant used in patients with peripheral artery disease and coronary artery disease.

FDA Approves LungFit PH to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

June 29, 2022

Article

The approval eliminates the need for traditional nitric oxide tanks in the hospital setting.

Study: Women Less Likely to Receive Timely Treatment for Heart Attacks

June 29, 2022

Article

Investigators also noted that Black, Hispanic, and Asian individuals were less likely than white individuals to undergo timely angiography and had minimal changes overtime.

New Recommendations Show How to Use Genetic Testing to Prevent Sudden Cardiac Death

June 27, 2022

Article

Clinical evaluation dictates the need for preventive therapy and advice on exercising and participation in competitive sports, according to the European Society of Cardiology.

Pharmacy Should be ‘Special’ for All Patients

June 22, 2022

Article

Even if the financial resources were available, there aren’t enough human resources in pharmacy to provide high-touch engagement to the millions of patients who suffer from common chronic diseases.

Study: Blood Pressure Drug May Lower Aneurysm Rupture Risk for People With High Blood Pressure

June 10, 2022

Article

Renin-angiotensin-aldosterone system inhibitors found to reduce the risk of an aneurysm rupture by 18%.

Clinical Overview: Inclisiran for Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease

June 07, 2022

Article

Inclisiran (Leqvio) is a small interfering ribonucleic acid approved by the FDA for patients who are on a maximally-tolerated dose of statins and need additional LDL-C reduction.

Pharmazz Releases Positive Results for Trial Evaluating Sovateltide for Acute Ischemic Stroke

June 02, 2022

Article

The findings show that at 90 days, the modified Rankin Score (mRS) had a significantly greater number of individuals with an improvement of 2 points or greater.

Studies Reinforce Efficacy of Rivaroxaban Plus Aspirin in Patients with Coronary Artery Disease, Peripheral Artery Disease

June 02, 2022

Article

These real-world findings help support the use of DPI in patients at increased risk of vascular events.

Study Emphasizes Need for Substantial Improvement in Heart Attack Outcomes Across High-Income Nations

June 01, 2022

Article

Efforts to decrease hospital readmissions may have been misguided because the United States are already doing better than other high-income nations in this area.